Bispecific Antibodies: An Emerging Class Of MBC Drugs
Bispecific antibodies are an emerging class of drugs in breast cancer clinical research. By binding to two distinct targets, a bispecific antibody can do two jobs...
Read Morefor past articles or specific information.